Search
Research
Roswell Park-University of Chicago Ovarian Cancer SPORE Clinical Trials
… contact the Principal Investigator (Clinical), Emese Zsiros, MD, PhD, FACOG . Upcoming clinical trials A Phase … contact the Principal Investigator (Clinical), Emese Zsiros, MD, PhD, FACOG . Upcoming clinical trials A Phase …
Cancer Types
Immunotherapy for Ovarian Cancer
… infused back into the patient. Become a patient Dr. Emese Zsiros explains some of the current clinical trials at …
Clinical Trial
A Phase 1, First-in-Human, Open-Label, DoseEscalation and Expansion Study of IMGN151 (anti-FR-alpha antibody drug conjugate) in Adult Patients with Recurrent Gynaecological Cancers
… in Adult Patients with Recurrent Gynaecological Cancers I Zsiros, Emese IIMGN151-1001 is a Phase 1, first in human, …
Clinical Trial
A phase 1a/b study to evaluate the safety and efficacy of OPB-101, an autologous mesothelin (MSLN) CAR T cell therapy with antigen-dependent expression of OUTSMART designed IL-2 cytokine in platinum-resistant ovarian cancer
… IL-2 cytokine in platinum-resistant ovarian cancer I Zsiros, Emese The goal of this clinical trial is to learn if …
Clinical Trial
A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Investigator s Choice (IC) in Patients with Platinum Resistant Ovarian Cancer
… in Patients with Platinum Resistant Ovarian Cancer III Zsiros, Emese This phase 3 study will be conducted in …
Clinical Trial
Randomized Phase 2 Clinical Trial of Pembrolizumab Combined with Bevacizumab with or without Agonist Anti-CD40 CDX-1140 in Patients with Recurrent Ovarian Cancer
… CDX-1140 in Patients with Recurrent Ovarian Cancer II Zsiros, Emese This phase II trial tests whether pembrolizumab …
News
Roswell Park Community Comes Together to Celebrate Outstanding Physicians
… a robotic approach to pancreaticoduodenectomy.” Emese Zsiros, MD, PhD, FACOG — Breaking Barriers Award for Visionary Leadership Dr. Zsiros, Chair of Gynecologic Oncology and the Shashi Lele, … status quo, and leads with clarity and courage. “Dr. Emese Zsiros has a rare and remarkable ability to transform vision …
Tumor Immunology & Immunotherapy Research Program
… Chair, Department of Immunology View the Abrams Lab Emese Zsiros, MD, PhD, FACOG Associate Professor of Oncology … Trial #: NCT04919629 Principal Investigator: Emese Zsiros, MD, PhD This Phase II trial studies the safety of … Cancer Trial #: NCT05231122 Principal Investigator: Emese Zsiros, MD, PhD This Phase II trial studies the safety and …
Blog Post
Coping with hair loss: Jerrolynn's story
… oncologists Katherine LaVigne Mager, MD, FACOG and Emese Zsiros, MD, PhD, FACOG. “Dr. Mager is a godsend and Dr. Zsiros was my first doctor here and integral in discovering … oncologists Katherine LaVigne Mager, MD, FACOG and Emese Zsiros, MD, PhD, FACOG. “Dr. Mager is a godsend and Dr. …
Department of Immunology Faculty
… Professor of Oncology Department of Immunology Emese Zsiros, MD, PhD, FACOG Associate Professor of Oncology …